Congress is considering health care reforms to lower costs, increase access, and empower doctors. As part of this legislative agenda, they may consider price controls. Price controls never work as advertised. They do not lower costs and do not increase access to new medicines. Instead, they allow the government to ration the supply and development of new life-saving medicines at the expense of consumers, patients, and doctors. To learn more about the negatives consequences of price controls, tune in to ATR President Grover Norquist’s latest podcast below: